U.S. markets open in 7 hours 27 minutes
  • S&P Futures

    4,127.00
    +9.00 (+0.22%)
     
  • Dow Futures

    33,699.00
    +75.00 (+0.22%)
     
  • Nasdaq Futures

    13,840.00
    +41.25 (+0.30%)
     
  • Russell 2000 Futures

    2,252.70
    +7.70 (+0.34%)
     
  • Crude Oil

    63.08
    -0.07 (-0.11%)
     
  • Gold

    1,742.40
    +6.10 (+0.35%)
     
  • Silver

    25.56
    +0.03 (+0.12%)
     
  • EUR/USD

    1.1977
    -0.0006 (-0.05%)
     
  • 10-Yr Bond

    1.6380
    0.0000 (0.00%)
     
  • Vix

    16.99
    +0.34 (+2.04%)
     
  • GBP/USD

    1.3768
    -0.0013 (-0.09%)
     
  • USD/JPY

    108.9210
    -0.0060 (-0.01%)
     
  • BTC-USD

    63,310.24
    -919.40 (-1.43%)
     
  • CMC Crypto 200

    1,381.28
    +5.50 (+0.40%)
     
  • FTSE 100

    6,939.58
    +49.09 (+0.71%)
     
  • Nikkei 225

    29,618.27
    -2.72 (-0.01%)
     

HTG Molecular to Present Corporate Overview at the Cowen & Company 39th Annual Health Care Conference

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cowen & Company 39th Annual Health Care Conference, being held in Boston, Mass. on March 11 – 13, 2019.

HTG Molecular Presentation Details

Date:

Monday, March 11

Time:

4:10 p.m. Eastern Time

Location:

Boston Marriott Copley Place, Boston, MA

Webcast:

http://wsw.com/webcast/cowen52/htgm/


About HTG:

HTG is focused on advancing precision medicine. The company’s proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG’s customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options.

Contact:

Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 535-7742
Email: arr@lifesciadvisors.com

Shaun McMeans
Chief Financial Officer
HTG Molecular Diagnostics, Inc.
Email: smcmeans@htgmolecular.com